Page last updated: 2024-08-23

tetradecanoylphorbol acetate and maraviroc

tetradecanoylphorbol acetate has been researched along with maraviroc in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belvisi, V; BranĂ , MT; Di Bari, G; Gramegna, P; Latronico, T; Lichtner, M; Liuzzi, GM; Mascellino, MT; Mastroianni, CM; Mengoni, F; Vullo, V1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and maraviroc

ArticleYear
In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection.
    PloS one, 2011, Volume: 6, Issue:12

    Topics: Animals; Astrocytes; Brain; CCR5 Receptor Antagonists; Cell Death; Cell Shape; Cell Survival; Cells, Cultured; Cyclohexanes; Down-Regulation; Gene Expression Regulation, Enzymologic; HIV Infections; Humans; Lipopolysaccharides; Maraviroc; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuroglia; Rats; Receptors, CCR5; RNA, Messenger; Tetradecanoylphorbol Acetate; Triazoles

2011